KEY PRODUCTS
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
01 1Siegfried AG
01 1BUPRENORPHINE
01 1Switzerland
01 1Active
01 1Complete
Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2014-05-16
Pay. Date : 2013-01-28
DMF Number : 26052
Submission : 2012-05-14
Status : Active
Type : II
20
Siegfried Ltd, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Siegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.
One of their notable products is BUPRENORPHINE, with a corresponding US DMF Number 26052.
Remarkably, this DMF maintains an Active status since its submission on May 14, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 16, 2014, and payment made on January 28, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
